Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.
Beachbody Company is back in focus as analysts revisit their price targets, with fair value estimates centered around US$18.0 and some targets extending up to US$22. Recent research ties these higher ranges to Q1 performance that analysts say supports more confidence in the company's ability to execute, even as legacy operations and the future product pipeline remain key watchpoints. As you read on, you will see how this evolving narrative is taking shape and what to watch to stay on top of the story.
Stay updated as the Fair Value for Beachbody Company shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Beachbody Company.
What Wall Street Has Been Saying
🐂 Bullish Takeaways
-
Noble Capital raised its price target on Beachbody Company to US$22 from US$15 after Q1 results, citing performance that exceeded expectations, even as legacy operations continue to run off.
-
Noble Capital kept an Outperform rating in place, indicating that its analysts see the current valuation as leaving room for Beachbody Company to execute on its plan despite ongoing business transitions.
-
Roth Capital lifted its price target to US$13 from US$10 following Q1 results, indicating that the firm updated its valuation framework in response to recent company performance.
🐻 Bearish Takeaways
-
Roth Capital maintained a Neutral rating, indicating that expectations remain balanced and that the firm is not leaning strongly positive on Beachbody Company at current levels.
-
Roth Capital also pointed to continued negative sequential trends in legacy businesses and uncertainty around product velocity from planned retail launches, which it views as key execution risks.
Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives!
We've flagged 2 risks for Beachbody Company. See which could impact your investment.
How This Changes the Fair Value For Beachbody Company
-
Fair value estimate for Beachbody Company is unchanged at US$18.0.
-
Revenue growth assumption is effectively steady, moving from 125.73% to 125.76%, which remains a very large implied growth rate.
-
Profit margin input is essentially unchanged, shifting marginally from 3.52% to 3.52% in the updated model.
-
Future P/E multiple has moved from 18.37x to 18.55x, applied to projected earnings.
-
Discount rate has risen slightly from 7.52% to 7.87% in the model.
Never Miss an Update: Follow The Narrative
Narratives connect Beachbody Company's business story to a set of financial assumptions and a fair value estimate, then refresh as new information comes in. They help you see how product launches, channel shifts, and risks all feed into the investment case.
Head over to the Simply Wall St Community and follow the Narrative on Beachbody Company to stay up to date on:
-
How Beachbody Company's move to an omnichannel model, including Shakeology and P90X retail launches, ties into the broader push toward holistic wellness and brand-led nutrition products.
-
The impact of exiting the MLM model, cutting selling and marketing costs, and leaning on data-driven personalization and AI tools to support subscription engagement and margins.
-
Key risks around ongoing revenue contraction in legacy digital and nutrition lines, competitive pressure from low cost fitness content, and uncertainty around retail traction and brand repositioning.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include BODI .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
